NEED A HELP? CALL US
Scientists at Nanoscope Technologies have shown pain inhibition by optogenetic modulation.http://pulse.embs.org/july-2016/feeling-no-pain/
Nanoscope Technologies has been awarded an Audacious Goal Initiative grant by the National Eye Institute for exploring novel laser based therapeutic gene delivery to the eye.
NanoScope Technologies has been awarded a NIH SBIR Grant from the National Eye Institute to advance the development and preclinical evaluation of the company's patent pending platform technology on nano-enhanced optical delivery of exogenous impermeable materials into targeted cells.
NanoScope researchers to present following research topic at SPIE Photonics West 2016 in San Francisco, CA.
Nano-enhanced optical delivery into targeted cellshttp://spie.org/PWB/conferencedetails/optogenetics
Nanoscope Technologies started international operation in India for R&D and translation of biomedical technologies.
NanoScope Technologies has been awarded a National Institutes of Health (NIH) Small Business Innovation Research Grant (R43/44 SBIR) from the National Eye Institute (NEI) to advance the development and preclinical evaluation of the company's patent pending platform technology on nano-enhanced optical delivery of exogenous impermeable materials into targeted cells. NanoScope researchers are focusing to translate this platform technology for delivering therapeutic genes into targeted areas of photo-degenerated retina in-vivo in case of geographic atrophies caused by dry-AMD.https://sbirsource.com/sbir/awards/155369-ambient-light-activatable-opsin-based-therapy-for-age-related-macular-degeneration
NanoScope technologies developed novel imaging method for characterization of intraocular lenses and started collaboration with Alcon.
NanoScope Chief Scientific Officer- Dr. Mohanty presented invited lecture at UT Dallas on.
Physical Cues for Axonal Guidance
NanoScope Technologies participated in research for development on New microscopy technique to visualize cells through the walls of silicon microfluidic devices.
6500 Greenville Ave., Ste 740, Dallas, TX 75206 | Phone: 626-244-5300 | Fax: 817-719-2692 | Mail: email@example.com
Copyright @ 2015 Nanoscope | All rights reserved